Recombinant vaccinia virus vaccine against the human melanoma antigen p97 for use in immunotherapy (Q33552626)

28 July 2017

Recombinant vaccinia virus vaccine against the human melanoma antigen p97 for use in immunotherapy (English)

1 reference

28 July 2017

1 reference

vaccinia virus

1 reference

3

Plowman GD

1 reference

28 July 2017

Estin CD

1

1 reference

28 July 2017

Stevenson US

2

1 reference

28 July 2017

Hu SL

4

1 reference

28 July 2017

Sridhar P

5

1 reference

28 July 2017

Hellström I

6

1 reference

28 July 2017

Brown JP

7

1 reference

28 July 2017

Hellström KE

8

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 February 1988

1 reference

Proceedings of the National Academy of Sciences of the United States of America

28 July 2017

1 reference

28 July 2017

85

1 reference

28 July 2017

4

1 reference

28 July 2017

1052-1056

1 reference

Heterogeneity in surface antigen and glycoprotein expression of cell lines derived from different melanoma metastases of the same patient. Implications for the study of tumor antigens

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=279699

Macrophage-mediated destruction of malignant tumor cells and new strategies for the therapy of metastatic disease

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=279699

Induction of immunity to a human tumor marker by in vivo administration of anti-idiotypic antibodies in mice

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=279699

General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=279699

Vaccinia virus: a selectable eukaryotic cloning and expression vector

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=279699

Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=279699

Third Gordon Hamilton-Fairley Memorial Lecture. Tumour markers—Where do we go from here?

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=279699

Suppressor mechanisms in tumor immunity

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=279699

Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=279699

Cellular Immunity Against Tumor Antigens

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=279699

Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=279699

Prospectively randomized trial of adjuvant active-specific immunotherapy for human colorectal cancer.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=279699

Monoclonal antiidiotypic antibodies related to a murine oncofetal bladder tumor antigen induce specific cell-mediated tumor immunity

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=279699

Strong antitumor activities of IgG3 antibodies to a human melanoma-associated ganglioside

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=279699

Monoclonal mouse antibodies raised against human lung carcinoma.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=279699

T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=279699

Characterization of a recombinant vaccinia virus expressing human melanoma-associated antigen p97.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=279699

T-cell responses to human AIDS virus in macaques immunized with recombinant vaccinia viruses

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=279699

Tumour prevention and rejection with recombinant vaccinia.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=279699

Immunologic selection of simian virus 40 (SV40) T-antigen-negative tumor cells which arise by excision of early SV40 DNA.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=279699

Primary structure of the human melanoma-associated antigen p97 (melanotransferrin) deduced from the mRNA sequence

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=279699

Suppression of in vivo tumor formation induced by simian virus 40-transformed cells in mice receiving antiidiotypic antibodies.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=279699

Antibody response and tumor growth in syngeneic mice immunized to partially purified B16 melanoma-associated antigens

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=279699

Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=279699

The isolation of immunogenic molecular entities from immunogenic and nonimmunogenic tumor homogenates by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=279699

Clonal variation in expression of a human melanoma antigen defined by a monoclonal antibody

31 October 2018

1 reference

12 December 2020

Biological and experimental consequences of the zonal composition of solid tumors

1 reference

12 December 2020

Structural characterization of human melanoma-associated antigen p97 with monoclonal antibodies

1 reference

12 December 2020

Immunization to a syngeneic sarcoma by a monoclonal auto-anti-idiotypic antibody

1 reference

12 December 2020

A phase I/II SECSG (Southeastern Cancer Study Group) pilot study of surgical adjuvant immunotherapy with vaccinia melanoma oncolysates (VMO)

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.85.4.1052

1 reference

28 July 2017

0 references

1 reference

28 July 2017

1 reference